Oncofusion

start / graph / gene-nasp

Geneweak confidence 2 of 5: Preliminary, small, indirect, or not yet peer reviewed.Q37-histone-chaperones

NASP - the soluble histone reservoir, and the only gene in this beat with a real selective difference at a pan-essentiality shallow enough to interpret

also called NASP · sNASP · tNASP · nuclear autoantigenic sperm protein · P49321

NASP holds a pool of spare histones in the cell so they are ready when needed and do not get destroyed in the meantime. How big that pool is sets how fast a cell can replace histones - which is the clock this project's main drug has to beat.

The same thing, for a scientist

NASP (P49321, 788 aa) is the major soluble H3-H4 chaperone. It binds H3 in two distinct modes - via the H3 alpha-3 helix and via the H3 alphaN region - and **shielding of the H3 alphaN region by NASP is essential for maintaining the soluble H3-H4 pool** [E1]. Structures of the sNASP dimer, sNASP with H3 alpha-3 peptides and the sNASP-H3-H4-ASF1b co-chaperone complex place it immediately upstream of ASF1 in the supply chain [E1][E2]. **Why it belongs in this beat and not in a general chromatin beat:** if H3K79 methylation is lost only when histones are replaced, then the **size and availability of the soluble histone pool is an upstream determinant of how fast replacement can happen**. NASP is the protein that sets it, and the pool is actively regulated - a Cyclin E/CDK2 circuit with feedback from soluble histone protein controls the S-phase burst of histone biosynthesis [E3]. **And unusually for this beat, the dependency number is interpretable.** NASP's difference is -0.163 at a pan-essentiality of **-0.463**, which is just inside this project's -0.5 convention for 'not dying everywhere' and just past its -0.15 convention for a selective difference [E4]. It is the only gene in the scan that satisfies both. That is not a hit - no permutation null was computed, and the sibling shortlist of larger differences did not survive one - but it is the one number in this beat that is not disqualified before it is read.

Go deeper
The reservoir as a rate term, stated so it can be tested

The clearance-clock argument treats replacement as if the supply of new histone were unlimited. It is not:

  • NASP maintains the soluble H3-H4 pool by shielding H3 alphaN; without it histones are degraded 1.
  • Histone biosynthesis is burst-controlled in S phase with feedback from the soluble pool itself 3.
  • In the Drosophila embryo NASP maintains H3-H4 reservoirs, which is the system where a reservoir's function is most directly visible 5.

So replacement rate = demand (transcription, replication) x supply (soluble pool) x deposition capacity (chaperones), and this beat's other entries only cover the third term. If supply is limiting in a quiescent cell - where the S-phase biosynthetic burst does not occur - then the clearance clock in a non-dividing cell is limited by the reservoir, not by the chaperones. Nobody has measured the soluble histone pool in a quiescent leukaemic cell.

Facts and figures
uniprotP49321
gene symbolNASP
length AA788
functionsoluble H3-H4 reservoir; shields the H3 alphaN region to prevent degradation; hands off to ASF1
kmt2a literature records0
leukaemia literature records title checked0
subnuclear localizationNONE ASSIGNED - a BOUNDED ABSENCE, and a tight one. NASP[tiab] against a twelve-term subnuclear clause returns 2 records and NEITHER is a NASP compartment study: PMID 36868228 is the DAXX histone-chaperone-network interactomics paper, in which DAXX rather than NASP recruits methyltransferases to catalyse H3K9me3 on new H3.3-H4 before deposition and thereby supplies a de novo HETEROCHROMATIN ASSEMBLY route, and PMID 23325853 is about Nap1 and CENP-B [E_q93_nasp_loc4]. WHAT NASP HAS INSTEAD OF A SUBNUCLEAR ADDRESS IS A POSITION IN A SUPPLY CHAIN: this entry's existing E1 and E2 place it immediately upstream of ASF1, shielding the H3 alphaN region to maintain the soluble H3-H4 pool, and the DAXX paper maps the same network. A position in a chaperone network is a biochemical address, not a compartment, and the distinction matters for this entry's own argument - a soluble pool is defined by NOT being on chromatin, so 'where is NASP' and 'how big is the reservoir' are close to the same question.
localization shown for fusionNO - nobody has looked, in any fusion, in any lineage, and the bound is as clean as any in this tranche: the gene clause over NASP, sNASP and tNASP returns 201 records, against a nine-term KMT2A/MLL fusion clause it returns ZERO, and against a localisation clause AND the fusion clause it returns ZERO [E_q93_nasp_loc4]. For this gene the fusion-context question is unusually well-posed by the entry's own mechanism: menin inhibition is supposed to work faster than histone replacement can restore H3K79 methylation, so the measurement this entry most wants is the size of the soluble H3-H4 pool - and therefore NASP's chromatin-free fraction - in a KMT2A-rearranged blast before and during menin inhibition. Nobody has measured NASP in such a cell at all.
depmap
index_mean-0.565index_mean: -0.5648pan_essentiality-0.463pan_essentiality: -0.4634other_leukaemia_mean-0.402other_leukaemia_mean: -0.4016lymphoid_difference-0.249lymphoid_difference: -0.2489difference-0.163difference: -0.1632myeloid_difference-0.118myeloid_difference: -0.1185n_index11.0n_index: 11
isoforms
[
  "sNASP (somatic)",
  "tNASP (testis)"
]
depmap — the numbers behind the chart
{
  "index_mean": -0.5648,
  "other_leukaemia_mean": -0.4016,
  "difference": -0.1632,
  "pan_essentiality": -0.4634,
  "myeloid_difference": -0.1185,
  "lymphoid_difference": -0.2489,
  "n_index": 11
}
depmap kmt2a selectivity
{
  "chronos_mean_kmt2a_rearranged": -0.5648,
  "chronos_mean_other_leukaemia": -0.4016,
  "difference": -0.1632,
  "pan_essentiality_all_lines": -0.4634,
  "selectivity_rank": 397,
  "rank_denominator": 17728,
  "provenance": "Joined 2026-09-21 from analyses/depmap-kmt2a-selective-scan-full (generated 2026-09-19T10:12:06Z), the project's own genome-wide scan over 11 KMT2A-rearranged and 43 other leukaemia DepMap lines. NOT re-fetched and NOT independent of that scan: every caveat it carries applies here, including that the KMT2A-rearranged arm is a small number of lines drawn from nine individuals, that the rank denominator is 17,728 genes, and that a difference is not a dependency. Added because only 26 of 308 gene entries carried this number, which made any KMT2A-selectivity question answerable for 8% of the corpus.",
  "how_to_read": "A negative difference means MORE required in KMT2A-rearranged lines than in other leukaemia lines. A rank near 17,728 is ANTI-selective. Neither is evidence of a fusion-driven dependency on its own: check pan_essentiality_all_lines before calling anything selective, and note that a paralogue-redundant gene can score near zero for reasons that have nothing to do with this disease - see ana-the-paralogue-redundancy-excuse-is-not-tested-and-my-proxy-decided-the-answer."
}
localization
{
  "CONSTITUTIVE": "CYTOPLASM AND NUCLEUS - and on the HUMAN record there is no experimental evidence for either. UniProt P49321 (fetched live 2026-09-21) carries 'Cytoplasm' and 'Nucleus', both on a single ECO:0000250 attributed to Q99MD9, plus a nuclear localization signal annotated at residues 716-722. Q99MD9 was fetched and read back in the same session: it is NASP_MOUSE, 773 aa against the human 788, and the mouse record carries the SAME two values on THREE independent ECO:0000269 citations - PubMed:10893414, 12509435 and 16728391 [E_q93_nasp_loc1].",
  "AND_THIS_IS_THE_INVERTING_CASE_THE_BRIEF_ASKED_FOR": "Opening the propagation chain IMPROVED the annotation instead of weakening it. The third mouse citation, PubMed:12509435, is not a mouse experiment at all: full-length tNASP fused to GFP TRANSFECTED INTO HeLa CELLS is efficiently transported into the nucleus within 2 h of translation in the cytoplasm, whereas an NLS-DELETION MUTANT IS RETAINED IN THE CYTOPLASM [E_q93_nasp_loc3]. That is a human-cell, NLS-resolved import experiment with a matched negative control, sitting behind a human ECO:0000250 that reads as though nothing human had been done. THIS IS THE THIRD RODENT-PROPAGATION CHAIN THIS BEAT HAS OPENED IN TWO TRANCHES AND THE FIRST WHERE THE CHAIN LED SOMEWHERE BETTER THAN THE LABEL.",
  "ISOFORM_SCOPED_AND_UNIPROT_FLATTENS_IT": "There are two major forms and they are not interchangeable: tNASP in gametes, embryonic cells and transformed cells, and sNASP in all rapidly dividing somatic cells, sNASP being a shorter splice form with two coding deletions [E_q93_nasp_loc2]. UniProt's tissue comment records only that 'Isoform 1 is testis- and sperm-specific'. The compartment experiments were done on tNASP-GFP; the form present in a leukaemic blast is sNASP, and it has never been localised. Same shape as KMT2A's fragments, DNMT3A's isoforms and CD33's isoforms elsewhere in this graph.",
  "how_shown": "GFP-tNASP transfection into HeLa with an NLS-deletion negative control (PMID 12509435); affinity chromatography and histone isolation establishing the H1-only complex in myeloma cells (PMID 10893414); knockdown in HeLa and U2OS plus a null mouse (PMID 16728391)",
  "systems": "HeLa and U2OS human lines, mouse embryonic cells, and MYELOMA CELLS for the histone-binding work - which is the only haematopoietic system in the set. No leukaemic cell, no KMT2A-rearranged cell",
  "node": "localization-chromatin-bound-versus-soluble-fraction-kmt2a"
}
cell type
{
  "measured_in": "HeLa and U2OS for the import and knockdown work; MYELOMA CELLS for the histone-binding characterisation, which is the only haematopoietic system in the localisation literature for this gene [E_q93_nasp_loc2]; mouse embryonic cells and a NASP-null mouse.",
  "expressed_in": "sNASP is present in ALL MITOTIC CELLS EXAMINED, including mouse embryonic cells and several mouse and human tissue culture lines [E_q93_nasp_loc2] - so the cell-type answer for the somatic form is 'every dividing cell', and the informative statement is the isoform split rather than a tissue.",
  "in_this_disease": "NOTHING. There is no NASP image, fractionation or compartment measurement in any leukaemic cell, and this entry's existing data.kmt2a_literature_records records how thin the fusion-context literature is.",
  "the_requirement_is_real_and_general": "Without sufficient NASP, HeLa and U2OS cells cannot replicate their DNA or progress through the cell cycle, and the NASP-null mutation causes embryonic lethality [E_q93_nasp_loc4] - consistent with this entry's existing DepMap profile and with the brief's warning that a general proliferative requirement is not a disease-specific node."
}
cell state
{
  "CELL_CYCLE_IS_THE_DOCUMENTED_STATE": "NASP was characterised as a CELL-CYCLE-REGULATED somatic protein [E_q93_nasp_loc2], and overexpressing tNASP affects progression through the cell cycle [E_q93_nasp_loc3]. So the abundance of the reservoir protein is itself phase-dependent, which is exactly the variable this entry's existing argument needs: if H3K79 methylation is lost only when histones are replaced, the size and availability of the soluble pool is a rate term, and that rate term oscillates.",
  "TRANSFORMATION_IS_THE_SECOND_STATE_AND_IT_IS_AN_ISOFORM_SWITCH": "tNASP is found in gametes, embryonic cells AND TRANSFORMED CELLS, while sNASP is the form in rapidly dividing somatic cells [E_q93_nasp_loc2]. A transformed cell is therefore expected to carry the isoform whose nuclear import was actually measured - which is a rare case in this beat where the relevant isoform in a malignant cell may be the one with the data, and it has never been checked in a leukaemic blast.",
  "bounded": "No NASP cell-state or localisation measurement exists in any leukaemic cell, and the tNASP-to-sNASP ratio has never been measured in a KMT2A-rearranged sample."
}
localization bounded absence
{
  "date": "2026-09-21",
  "tool": "NCBI E-utilities esearch, db=pubmed",
  "run_by": "Q93",
  "queries": [
    {
      "query": "(\"NASP\"[tiab] OR \"sNASP\"[tiab] OR \"tNASP\"[tiab])",
      "querytranslation": "\"NASP\"[Title/Abstract] OR \"sNASP\"[Title/Abstract] OR \"tNASP\"[Title/Abstract]",
      "count": 201,
      "role": "operand control"
    },
    {
      "query": "(gene clause) AND (twelve-term subnuclear clause)",
      "count": 2,
      "title_check": "0 on topic for a NASP compartment. PMID 36868228 (DAXX adds a de novo H3.3K9me3 deposition pathway to the histone chaperone network) and PMID 23325853 (Nap1 and CENP-B binding to nucleosomes).",
      "bound_not_reproducible_as_stored": "NOT REPRODUCIBLE AS STORED, flagged 2026-09-23. This `query` field records a SUMMARY of the search rather than the search: the clause text it names was never written down, so the string cannot be re-run and this bound could not be included in the cycle-71 audit that re-ran 40 of the corpus's other zero-bounds against the live index (all 40 still returned zero). The clauses have deliberately NOT been reconstructed - guessing them would manufacture a query that was never run, which is worse than an abbreviated one because it would look auditable. This flag does not dispute the count or the absence; it records that this particular bound is not independently checkable."
    },
    {
      "query": "(gene clause) AND (nine-term KMT2A/MLL fusion clause)",
      "count": 0,
      "bound_not_reproducible_as_stored": "NOT REPRODUCIBLE AS STORED, flagged 2026-09-23. This `query` field records a SUMMARY of the search rather than the search: the clause text it names was never written down, so the string cannot be re-run and this bound could not be included in the cycle-71 audit that re-ran 40 of the corpus's other zero-bounds against the live index (all 40 still returned zero). The clauses have deliberately NOT been reconstructed - guessing them would manufacture a query that was never run, which is worse than an abbreviated one because it would look auditable. This flag does not dispute the count or the absence; it records that this particular bound is not independently checkable."
    },
    {
      "query": "(gene clause) AND (localisation clause) AND (fusion clause)",
      "count": 0,
      "bound_not_reproducible_as_stored": "NOT REPRODUCIBLE AS STORED, flagged 2026-09-23. This `query` field records a SUMMARY of the search rather than the search: the clause text it names was never written down, so the string cannot be re-run and this bound could not be included in the cycle-71 audit that re-ran 40 of the corpus's other zero-bounds against the live index (all 40 still returned zero). The clauses have deliberately NOT been reconstructed - guessing them would manufacture a query that was never run, which is worse than an abbreviated one because it would look auditable. This flag does not dispute the count or the absence; it records that this particular bound is not independently checkable."
    },
    {
      "query": "NASP[tiab] AND (nuclear[tiab] OR nucleus[tiab] OR cytoplasm[tiab])",
      "querytranslation": "\"NASP\"[Title/Abstract] AND (\"nuclear\"[Title/Abstract] OR \"nucleus\"[Title/Abstract] OR \"cytoplasm\"[Title/Abstract])",
      "count": 65,
      "role": "inflated by the protein's own name - Nuclear Autoantigenic Sperm Protein contains the word nuclear, so the term matches the expansion of the acronym in essentially every paper about it. Not usable as a localisation count."
    }
  ],
  "acronym_trap": "NASP EXPANDS TO 'NUCLEAR AUTOANTIGENIC SPERM PROTEIN'. Any query pairing this symbol with 'nuclear' matches papers that merely spell the name out, so a 65-record count means nothing. This is the mirror of the contaminated-token problem elsewhere in this tranche: there the off-topic literature supplied the word, here the gene's own name does.",
  "reading": "Titles and abstracts only; supporting figures not searched (brief rule 80).",
  "absence_class": "never-measured"
}
How this could bite us back
  • NASP prevents degradation of free histones in every cell; blocking it would deplete the histone pool genome-wide, which is toxic to any proliferating tissue and has no described window.
  • Reducing the soluble histone reservoir slows replacement, which by this graph's clearance-clock argument makes H3K79 methylation persist longer - so a NASP inhibitor is predicted to antagonise a DOT1L inhibitor.
  • Free histones are cytotoxic; perturbing the chaperone that shields them risks releasing them rather than merely reducing deposition, a failure mode with a different and less predictable toxicity than simple loss of function.
Still open
  1. Run a permutation null on the NASP difference. It is the only number in this beat that passes both of this project's conventions and it has not been tested; the sibling shortlist with larger differences did not survive one.
  2. How large is the soluble H3-H4 pool in a quiescent leukaemic cell, and does it limit histone replacement there? If it does, the clearance clock in a non-dividing cell is a supply problem rather than a deposition problem.
  3. Does DOT1L inhibition change the soluble histone pool? If the drug's effect depends on replacement and replacement depends on supply, the two are coupled and nobody has looked.
Every source behind this entry (9)
  1. E1established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    NASP is a major histone chaperone for H3-H4 dimers critical for preventing histone degradation; structures of an sNASP dimer, of sNASP with two H3 alpha-3 peptides, and of the sNASP-H3-H4-ASF1b co-chaperone complex identify two distinct binding modes involving the H3 alpha-3 helix and the H3 alphaN region; functional studies show the H3 alphaN interaction is the major binding mode in cells and that shielding of the H3 alphaN region by NASP is essential for maintaining the soluble H3-H4 pool.

    NASP maintains histone H3-H4 homeostasis through two distinct H3 binding modes. · Bao H, Carraro M, Flury V, et al. · Nucleic Acids Research 2022
    What this evidence cannot show

    Abstract read from efetch 2026-09-20; full text not read (PMC9122598 exists). Structural biology plus cell-based functional tests in a non-haematopoietic human system; established for the interactions and the pool phenotype in that system. No leukaemia and no KMT2A fusion. **No residue spans are stored in this entry** because they were not derived by alignment to a freshly fetched UniProt sequence.

    Evidence that argues against this (1)
    • An independent structural study of sNASP H3-H4 binding modes frames the same chemistry as the basis for cooperation AND competition among chaperones, which means NASP's contribution to the soluble pool is set by the rest of the network rather than by NASP alone - so a NASP perturbation is not a clean pool perturbation. Liu CP et al. 2021
  2. E2strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    Distinct histone H3-H4 binding modes of sNASP reveal the basis for cooperation and competition among histone chaperones.

    What this evidence cannot show

    Record fetched from efetch 2026-09-20 for title, authors and DOI; the abstract was read and the full text was not. Cited for the network framing - that the chaperones compete for the same histone - rather than for any specific structural detail.

    Evidence that argues against this (1)
    • A competition model derived from binding modes in vitro does not establish which chaperone wins in a cell, where local concentration and recruitment dominate. The network's behaviour has been mapped by interactomics rather than solved, and that map is explicitly exploratory. Carraro M et al. 2023
  3. E3strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    Cyclin E/CDK2 and feedback from soluble histone protein regulate the S-phase burst of histone biosynthesis.

    What this evidence cannot show

    Record fetched from efetch 2026-09-20 for title, authors and DOI; the abstract was read and the full text was not (PMC10440735 exists). Cited for the existence of feedback between the soluble pool and histone production. Non-haematopoietic human cells; the quantitative form of the feedback is not assessed here.

    Evidence that argues against this (1)
    • This is a statement about S phase. Its relevance to a quiescent cell - the case this beat cares about most - is that the burst does NOT occur there, which is an inference from the paper rather than a result in it, and no measurement of the soluble pool in a quiescent leukaemic cell exists. Li Y et al. 2019
  4. E4weak confidence 2 of 5: Preliminary, small, indirect, or not yet peer reviewed.dataset

    In DepMap CRISPR gene effect, NASP's mean effect is -0.565 in 11 KMT2A-rearranged leukaemia lines against -0.402 in 43 other leukaemia lines (difference -0.163) at a pan-essentiality of -0.463 across 1,208 lines; myeloid difference -0.119, lymphoid difference -0.249. It is the only gene of the 29 scanned in this beat whose difference passes -0.15 while its pan-essentiality stays shallower than -0.5.

    What this evidence cannot show

    Run 2026-09-20. **Weak, deliberately.** No permutation null was computed, and this project's sibling triage produced a shortlist with LARGER differences - DAXX at -0.305 - that a 50,000-label permutation null subsequently killed (p = 0.0128, failing Bonferroni over 254 genes). A gene selected from 29 by passing two of this project's conventions is a gene selected post hoc. The lymphoid half is 4 lines and DepMap contains no infant KMT2A::AFF1 line. **This number is a reason to run a null, not a finding.**

    Evidence that argues against this (1)
    • The instrument that produced this number has a documented false positive at the top of a sibling ranking and a shortlist that did not survive correction. A smaller difference from the same instrument on the same lines cannot carry more weight than the one that failed. Oncofusion knowledge graph (internal analysis) 2026
  5. E5established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    The histone chaperone NASP maintains H3-H4 reservoirs in the early Drosophila embryo. NASP is UniProt P49321 (NASP_HUMAN), nuclear autoantigenic sperm protein, 788 amino acids, with no alias gene symbols in the reviewed record. As of 2026-09-20 'NASP AND leukemia' returns 3 PubMed records and all three are off-topic on title check - two asparaginase pharmacokinetics studies and a spermatogonial splicing paper.

    The histone chaperone NASP maintains H3-H4 reservoirs in the early Drosophila embryo. · Tirgar R, Davies JP, Plate L, et al. · PLoS Genetics 2023
    What this evidence cannot show

    Record fetched from efetch 2026-09-20 for title, authors and DOI; abstract read, full text not read (PMC10058107 exists). **Drosophila embryo**, the most reservoir-dependent system available and therefore the least generalisable. The UniProt record was fetched the same day with `gene_primary` requested and read back per rule 62. The literature counts come from esearch with translations captured and no [UID] term; **note that 'NASP' is a substring-adjacent token to 'asparaginase' in practice and every returned title had to be read** - a raw count of 3 would have looked like a small real literature.

    Evidence that argues against this (1)
    • A reservoir function demonstrated in an embryo with a massive maternal histone store says little about a leukaemic blast, which synthesises its histones as it cycles. The human structural work is the load-bearing evidence for NASP's pool function and the embryo result is an illustration. Bao H et al. 2022
  6. E_q93_nasp_loc1established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.database

    Human NASP's two UniProt subcellular locations, Cytoplasm and Nucleus, both rest on a single ECO:0000250 attributed to Q99MD9 = NASP_MOUSE (773 aa against the human 788), whose own record carries the same two values on three independent ECO:0000269 citations, PubMed:10893414, 12509435 and 16728391; the human record also annotates a nuclear localization signal at residues 716-722.

    What this evidence cannot show

    A statement about the record. The 15-residue difference between human and mouse is within the range where the length check is a weak defence, though better than the identical-length CTR9 and CSNK2A2 pairs in this tranche. The propagation is one of three found by this beat, and it is the only one whose underlying evidence is more than a single paper.

    Evidence that argues against this (1)
    • The propagation label understates the evidence here rather than overstating it, which is the opposite of the other two cases this beat found, and the reason is a curation artefact worth naming: the mouse record accumulated citations from a single laboratory's series, and one of those papers - PubMed:12509435 - performed its key import experiment in HUMAN HeLa CELLS. So an ECO:0000250 on the human protein is backed, at one remove, by a human-cell experiment. A reader applying brief rule 91's filter strictly, and discarding the human entry's by-similarity call as unmeasured, would discard a real human measurement along with it. Alekseev OM et al. 2003
  7. E_q93_nasp_loc2established confidence 5 of 5: Multiple independent lines of evidence; treated as settled in the field.paper

    A somatic form of NASP (sNASP) is present in ALL MITOTIC CELLS EXAMINED including mouse embryonic cells and several mouse and human tissue-culture lines; NASP purified from MYELOMA CELLS is complexed only with H1 linker histones; sNASP is a shorter version of testicular tNASP with two coding-region deletions arising from alternative splicing; and NASP is a cell-cycle-regulated protein, with tNASP found in gametes, embryonic cells and TRANSFORMED cells.

    Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein. · Richardson RT, Batova IN, Widgren EE, Zheng LX, Whitfield M, Marzluff WF, O'Rand MG · J Biol Chem 2000
    What this evidence cannot show

    2000-era biochemistry - affinity chromatography and histone isolation rather than imaging - so this establishes the isoform split, the cell-cycle regulation and the H1 specificity, not a compartment. The myeloma-cell work is the only haematopoietic system in this gene's localisation literature and it is a plasma-cell malignancy, not a lymphoblast (brief rule 73). The H1-only claim has since been broadened by the field, since NASP is now described as the major soluble H3-H4 chaperone in this entry's own existing E1. Bounded by the abstract.

    Evidence that argues against this (1)
    • The H1-versus-H3-H4 discrepancy is not a small one and the graph should hold both. This paper reports NASP from myeloma cells complexed ONLY with H1 linker histones; this entry's existing evidence describes NASP as the major soluble H3-H4 chaperone with structures of the sNASP dimer, sNASP with H3 alpha-3 peptides and the sNASP-H3-H4-ASF1b co-chaperone complex. Both cannot be the whole story, and the likeliest reconciliation - that the ISOFORM and the cell type decide which histone NASP is holding - would make the reservoir this entry treats as a rate term isoform-dependent too. Nobody has measured which histone sNASP holds in a leukaemic blast. Richardson RT et al. 2006
  8. E_q93_nasp_loc3strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.paper

    In HUMAN HeLa CELLS, full-length tNASP fused to GFP is efficiently transported into the nucleus within 2 h after translation in the cytoplasm, whereas an NASP NLS-deletion mutant fused to GFP is retained in the cytoplasm; overexpression of tNASP affects progression through the cell cycle.

    Overexpression of the Linker histone-binding protein tNASP affects progression through the cell cycle. · Alekseev OM, Bencic DC, Richardson RT, Widgren EE, O'Rand MG · J Biol Chem 2003
    What this evidence cannot show

    HeLa cells, not haematopoietic and not fusion-bearing (brief rule 73, and the claim names the system first). The construct is a GFP fusion of the TESTICULAR isoform, not the somatic sNASP present in dividing somatic cells including blasts, and transient transfection is an overexpression condition. What it establishes well is that the annotated NLS is functional and necessary; what it does not establish is the resting partition of the endogenous somatic protein. Bounded by the abstract.

    Evidence that argues against this (1)
    • The isoform mismatch is the objection, and it is specific rather than pedantic. sNASP differs from tNASP by two coding deletions arising from alternative splicing, and the annotated NLS sits at residues 716-722 - near the C-terminus of a 788-residue protein - so whether the somatic form even retains the signal that this experiment shows is required is a question the abstract does not answer and this graph cannot resolve from the record. The entry therefore records a functional NLS demonstrated on the testicular isoform and an unmeasured partition for the somatic one, rather than a single compartment for the gene. Richardson RT et al. 2000
  9. E_q93_nasp_loc4strong confidence 4 of 5: Replicated in peer-reviewed work by more than one group.database

    Bounded 2026-09-21: the NASP gene clause over NASP, sNASP and tNASP returns 201 records, against a twelve-term subnuclear clause returns 2 of which 0 are NASP compartment studies, against a nine-term KMT2A/MLL fusion clause returns 0, and against a localisation clause AND the fusion clause returns 0; separately, without sufficient NASP, HeLa and U2OS cells cannot replicate their DNA or progress through the cell cycle, and the NASP-null mutation causes embryonic lethality.

    What this evidence cannot show

    Titles and abstracts only; supporting figures not searched (brief rule 80). The requirement statement in the second clause is from PubMed:16728391 rather than from the query and is included because it is the cell-type-level consequence that the compartment record lacks. NASP[tiab] paired with 'nuclear' returns 65 records and is unusable, because the gene's name expands to Nuclear Autoantigenic Sperm Protein.

    Evidence that argues against this (1)
    • The zero against the fusion clause is clean, but the more useful observation is that the nearest relevant literature is about a DIFFERENT chaperone and reframes what NASP's compartment question even is. Interactomics of the human H3-H4 chaperone network shows DAXX providing a unique function - recruiting histone methyltransferases to catalyse H3K9me3 on NEW H3.3-H4 PRIOR TO DEPOSITION - so a mark can be written on a histone while it is still in the soluble pool, before it reaches chromatin. If that is general, then 'where is the histone' and 'where is the chaperone' stop being separable questions, and the reservoir this entry treats as a passive rate term is a site of modification. Nothing in that paper is about NASP's own address, and nothing is in a leukaemic cell. Carraro M et al. 2023
Connected to